Departments of Medicine and, †Epidemiology and Public Health, School of Medicine and, ‡Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland, §Fairleigh Dickinson University, Pharmacy Practice Division, School of Pharmacy, Florham Park, New Jersey.
Clin J Am Soc Nephrol. 2013 Dec;8(12):2123-31. doi: 10.2215/CJN.12671212. Epub 2013 Sep 19.
The Agency for Healthcare and Research Quality patient safety indicators track adverse safety events in hospitalized patients but overlook safety incidents specific to CKD. This study considers candidate CKD-pertinent patient safety indicators and compares them with the Agency for Healthcare and Research Quality patient safety indicators.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using a national Veterans Health Administration database of hospitalized veterans from fiscal year 2005, 247,160 hospitalized veterans with prehospitalization measures of renal function were retrospectively examined for proposed CKD patient safety indicators versus Agency for Healthcare and Research Quality patient safety indicators using International Classification of Diseases, Ninth Revision diagnosis codes. Candidate CKD-pertinent patient safety indicators included in-hospital acute kidney failure; in-hospital congestive heart failure (and related diagnostic codes); electrolyte disturbances; and medication errors, poisoning, and intoxication. Patients with a prehospital estimated GFR<60 ml/min per 1.73 m(2) (CKD group) were compared with a non-CKD group. For CKD patient safety indicators, hospitalizations were excluded if the admitting condition was a potential cause of the secondary condition. Regression methods were used to present adjusted rates in study groups of interest.
The CKD patient safety indicators were generally more common than the Agency for Healthcare and Research Quality patient safety indicators in all groups, tended to occur in different patients than those patients who experienced Agency for Healthcare and Research Quality patient safety indicators, and were more common in the CKD group than the non-CKD group, except for hypoglycemia, hypokalemia, and hyponatremia. The adjusted composite CKD patient safety indicators rate (per 1000 patient-hospitalizations) was 398.0 (95% confidence interval, 391.2 to 405.0) for patients in the CKD group and 250.0 (95% confidence interval, 247.4 to 252.7) for patients in the non-CKD group. The prevalence ratio of CKD patient safety indicators to Agency for Healthcare and Research Quality patient safety indicators was 23.4 (95% confidence interval, 21.9 to 25.0).
The candidate CKD patient safety indicators that occur in hospitalized patients are distinct from the Agency for Healthcare and Research Quality patient safety indicators and tend to be more common in CKD than non-CKD patients. These measures have the potential to serve as sentinel tools for identifying patients with CKD who warrant examination for disease-pertinent safety events.
医疗保健和研究质量机构的患者安全指标可追踪住院患者的不良安全事件,但忽略了特定于 CKD 的安全事件。本研究考虑了候选 CKD 相关的患者安全指标,并将其与医疗保健和研究质量机构的患者安全指标进行了比较。
设计、设置、参与者和测量方法:使用国家退伍军人健康管理局 2005 财年住院退伍军人的数据库,回顾性地检查了 247160 名有预住院肾功能测量值的住院退伍军人,以使用国际疾病分类,第九版诊断代码检查拟议的 CKD 患者安全指标与医疗保健和研究质量机构的患者安全指标。纳入的 CKD 相关患者安全指标包括院内急性肾衰竭;院内充血性心力衰竭(和相关诊断代码);电解质紊乱;以及药物错误、中毒和中毒。将预估计肾小球滤过率<60 ml/min/1.73 m²(CKD 组)的患者与非 CKD 组进行比较。对于 CKD 患者安全指标,如果入院情况是次要情况的潜在原因,则排除该住院治疗。回归方法用于报告研究组中感兴趣的调整后发生率。
在所有组中,CKD 患者安全指标通常比医疗保健和研究质量机构的患者安全指标更为常见,与经历医疗保健和研究质量机构的患者安全指标的患者相比,往往发生在不同的患者中,并且在 CKD 组中比非 CKD 组更常见,除了低血糖、低钾血症和低钠血症。CKD 患者安全指标的复合调整率(每 1000 例患者-住院治疗)为 398.0(95%置信区间,391.2 至 405.0),CKD 组患者为 250.0(95%置信区间,247.4 至 252.7),非 CKD 组患者为 250.0(95%置信区间,247.4 至 252.7)。CKD 患者安全指标与医疗保健和研究质量机构的患者安全指标的患病率比为 23.4(95%置信区间,21.9 至 25.0)。
发生在住院患者中的候选 CKD 患者安全指标与医疗保健和研究质量机构的患者安全指标不同,并且在 CKD 患者中比非 CKD 患者更为常见。这些措施有可能成为识别需要检查与疾病相关的安全事件的 CKD 患者的哨兵工具。